Sort
23,748 grants matching “melanoma”
The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy
$388,273Benjamin Izar · Columbia University Health Sciences · R01 · FY2024 · CA
In vivo murine models of metastasis for therapeutic testing
$388,202Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2014 · CA
Nucleic acid modulators and theranostics for ADAR
$388,125Guizhi Zhu · Virginia Commonwealth University · R35 · FY2021 · GM
Melanocyte boundary interactions in development and neoplasia
$388,091David M Parichy · University Of Washington · R01 · FY2011 · GM
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
$388,025David B. Solit · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
$388,025David B. Solit · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
$388,025David B. Solit · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
Project 4
$387,979Eva Hernando · New York University School Of Medicine · P50 · FY2025 · CA
Mechanism-based strategies to target oncogenic BRAF signaling
$387,886Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Mechanism-based strategies to target oncogenic BRAF signaling
$387,886Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Multiplex matrix ELISA for T cell protein-interaction networks in cancer
$387,880Adam G. Schrum · University Of Missouri-Columbia · R33 · FY2018 · CA
Structure and Function of Thrombospondin-1
$387,843Beth Israel Deaconess Medical Center · R01 · FY2004 · HL
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
$387,785Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2019 · CA
Investigating T Cell Egress via Lymphatic Vessels in Melanoma
$387,731Amanda W. Lund · New York University School Of Medicine · R01 · FY2020 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$387,731Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA
Investigating T Cell Egress via Lymphatic Vessels in Melanoma
$387,731Amanda W. Lund · New York University School Of Medicine · R01 · FY2022 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$387,731Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Differential role of different NAD+ kinase Isoforms in melanoma metastasis
$387,731Elena Piskounova · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
$387,731Sohail F. Tavazoie · Rockefeller University · R01 · FY2016 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$387,731Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
$387,731Sohail F. Tavazoie · Rockefeller University · R01 · FY2017 · CA
NK cell exhaustion in metastatic melanoma
$387,731Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Investigating T Cell Egress via Lymphatic Vessels in Melanoma
$387,731Amanda W. Lund · New York University School Of Medicine · R01 · FY2021 · CA
NK cell exhaustion in metastatic melanoma
$387,731Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
$387,731Sohail F. Tavazoie · Rockefeller University · R01 · FY2018 · CA